MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, VRCA made $35,577K in revenue. -$17,886K in net income. Net profit margin of -50.27%.

Income Overview

Revenue
$35,577K
Net Income
-$17,886K
Net Profit Margin
-50.27%
EPS
-$1.68
Unit: Thousand (K) dollars
Revenue Breakdown
    • License And Collaboration Revenu...
    • Product

Income Statement
2025-12-31
Total revenue
35,577
Cost of product revenue
2,192
Cost of license and collaboration revenue
1,249
Selling, general and administrative
35,220
Research and development
8,855
Loss on disposal of equipment
-246
Total operating expenses
47,762
Loss from operations
-12,185
Interest income
929
Interest expense
7,742
Change in fair value of derivative liability
2,648
Loss on extinguishment of debt
-1,533
Other expense
-3
Total other expense, net
-5,701
Net loss
-17,886
Basic EPS
-1.68
Diluted EPS
-1.68
Basic Average Shares
10,652,367
Diluted Average Shares
10,652,367
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$17,886K License AndCollaboration Revenue$20,292K Product$15,285K Loss from operations-$12,185K Total other expense,net-$5,701K Total revenue$35,577K Change in fair value ofderivative liability$2,648K Interest income$929K Total operatingexpenses$47,762K Interest expense$7,742K Loss onextinguishment of debt-$1,533K Other expense-$3K Selling, general andadministrative$35,220K Research and development$8,855K Cost of productrevenue$2,192K Cost of license andcollaboration revenue$1,249K Loss on disposal ofequipment-$246K

Verrica Pharmaceuticals Inc. (VRCA)

Verrica Pharmaceuticals Inc. (VRCA)